PubRank

Wilbur Franklin

Author PubWeight™ 54.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 21.49
2 Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. J Clin Oncol 2008 4.82
3 Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009 4.59
4 Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res 2006 3.21
5 Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed. J Thorac Oncol 2011 2.88
6 Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays. Bioinformatics 2004 2.04
7 Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2012 1.98
8 The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 2008 1.95
9 WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U S A 2003 1.78
10 Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010 1.66
11 The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res 2005 1.64
12 Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2012 1.45
13 Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004 1.34
14 Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol 2002 1.31
15 High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol 2012 1.28
16 A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer. J Thorac Oncol 2012 1.01
17 Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Clin Cancer Res 2012 0.97
18 Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. Biochim Biophys Acta 2005 0.89
19 Molecular and physiologic evidence for 5'CpG island methylation of the endothelin B receptor gene in lung cancer. Chest 2002 0.83
20 Biomarkers are here to stay for clinical research and standard care. J Thorac Oncol 2010 0.78
21 Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. Int J Radiat Oncol Biol Phys 2010 0.78
22 Prostacyclin in human non-small cell lung cancers. Chest 2004 0.76
23 SWOG Cooperative Group biorepository resource: access for scientific research studies. Clin Cancer Res 2011 0.75
24 Dramatic response to pemetrexed in a patient with pneumonic-type mucinous bronchioloalveolar carcinoma. J Thorac Oncol 2011 0.75
25 Sputum dysplasia, related to bacterial load, oxidative stress, and airway inflammation in COPD. Chest 2004 0.75
26 Airway antioxidants and oxidative stress as predictors of sputum atypia and airflow obstruction. Chest 2004 0.75
27 Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC. Oncology (Williston Park) 2009 0.75